Compositions comprising an hiv protease inhibitor

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 277/06 (2006.01) A61K 31/425 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2547404

The present invention relates to pharmaceutical compositions comprising amorphous (4R)-N-allyl-3-{(2S,3S)-2-hydroxy-3-[(3-hydroxy-2- methylbenzoyl)amino]-4-phenylbutanoyl}-5,5-dimethyl-1,3-thiazolidine-4- carboxamide, or a pharmaceutically acceptable salt or solvate thereof, their methods of preparation, their use in inhibiting the HIV protease enzyme, and their use in the manufacture of a medicament for the treatment HIV-infected mammals, such as humans.

La présente invention concerne des compositions pharmaceutiques comportant du (4R)-N-allyl-3-{(2S, 3S)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylbutanoyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxamide amorphe, ou un sel ou un solvate pharmaceutiquement acceptable de ce dernier, leurs procédés de préparation, leur utilisation pour l'inhibition de la protéase du VIH, et leur utilisation dans la fabrication d'un médicament pour le traitement de mammifères présentant une infection au VIH, tels que l'être humain.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions comprising an hiv protease inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions comprising an hiv protease inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising an hiv protease inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721824

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.